EIKEN肺炎鏈球菌檢測(cè)試劑盒

廣州健侖生物科技有限公司

主要用途：用于檢測(cè)尿標(biāo)本中的肺炎鏈球菌抗原，以支持肺炎鏈球菌感染的診斷。

產(chǎn)品規(guī)格：20T/盒

存儲(chǔ)條件：2-30℃

EIKEN肺炎鏈球菌檢測(cè)試劑盒

我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒：登革熱、瘧疾、西尼羅河、立克次體、無(wú)形體、蜱蟲(chóng)、恙蟲(chóng)、利什曼原蟲(chóng)、RK39、漢坦病毒、深林腦炎、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲(chóng)病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測(cè)、食品安全檢測(cè)等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

歡迎咨詢

歡迎咨詢2042552662

【產(chǎn)品介紹】

EIKEN

二維碼掃一掃

【公司名稱】 廣州健侖生物科技有限公司
【】    楊永漢 
【】 
【騰訊 】 2042552662
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-3室
【企業(yè)文化】

當(dāng)一個(gè)信號(hào)分子結(jié)合到細(xì)胞表面的RTKs，兩種受體相互結(jié)合的過(guò)程稱為二聚化作用。這個(gè)過(guò)程會(huì)激活細(xì)胞的信號(hào)轉(zhuǎn)導(dǎo)。Janovjak，格呂施和同事將哺乳動(dòng)物的RTKs的那些部分與光 - 氧 - 電壓傳感領(lǐng)域(鑒定黃綠藻的可逆光傳感器)結(jié)合。在工程化受體中，二聚化步驟和隨后的細(xì)胞信號(hào)轉(zhuǎn)導(dǎo)現(xiàn)在可以通過(guò)光隨著藻蛋白光感打開(kāi)和關(guān)閉，以及彼此結(jié)合。在腫瘤細(xì)胞中，工程受體的活化導(dǎo)致細(xì)胞形態(tài)變化，細(xì)胞增殖和基因表達(dá)，增加癌癥的惡性程度的特性。在血細(xì)胞中，活化導(dǎo)致細(xì)胞出芽，典型的新血管形成。
RTKs通過(guò)光激活二聚化作用調(diào)節(jié)發(fā)育是哺乳動(dòng)物受體的光激活二聚化作用的*個(gè)實(shí)例。光控制下的RTK提供了強(qiáng)大的光遺傳學(xué)的方法來(lái)啟動(dòng)細(xì)胞信號(hào)和操縱細(xì)胞的行為。新開(kāi)發(fā)的受體引發(fā)癌癥和血液中內(nèi)皮細(xì)胞復(fù)雜的細(xì)胞活動(dòng)。這些細(xì)胞代表根據(jù)光控行為的新模型，以及能夠用新的方法來(lái)確定藥物。這與癌細(xì)胞的相反，細(xì)胞信號(hào)轉(zhuǎn)導(dǎo)的不受控制的活化導(dǎo)致惡性腫瘤有關(guān)的特征，信號(hào)轉(zhuǎn)導(dǎo)的光激活可能拯救退行性疾病的細(xì)胞存活和功能。“漸凍癥”是運(yùn)動(dòng)神經(jīng)元病的一種，患者逐漸喪失運(yùn)動(dòng)機(jī)能甚至癱瘓，其中有名的是英國(guó)科學(xué)家霍金。這種病被認(rèn)為與神經(jīng)膠質(zhì)細(xì)胞異常有關(guān)，神經(jīng)膠質(zhì)細(xì)胞可負(fù)責(zé)維持神經(jīng)細(xì)胞的網(wǎng)絡(luò)并向神經(jīng)細(xì)胞提供營(yíng)養(yǎng)。
京都大學(xué)教授井上治久率領(lǐng)的研究小組，利用ips細(xì)胞制作出可變化為神經(jīng)膠質(zhì)細(xì)胞的前驅(qū)細(xì)胞，然后向24只患有漸凍癥的實(shí)驗(yàn)鼠脊髓各移植了約8萬(wàn)個(gè)這種細(xì)胞。
結(jié)果發(fā)現(xiàn)，移植了前驅(qū)細(xì)胞的24只漸凍癥實(shí)驗(yàn)鼠的平均生存期為162天，而沒(méi)有移植的24只實(shí)驗(yàn)鼠僅為150天。研究小組說(shuō)，移植的前驅(qū)細(xì)胞幾乎全部變?yōu)樯窠?jīng)膠質(zhì)細(xì)胞之一的星形膠質(zhì)細(xì)胞，開(kāi)始產(chǎn)生維持神經(jīng)細(xì)胞所需的蛋白質(zhì)，而且這些移植的細(xì)胞沒(méi)有發(fā)生癌變。

When a signaling molecule binds to a cell surface RTKs, the two receptors bind to each other as a dimerization. This process activates cell signaling. Janovjak, Gruch and colleagues combined those parts of the mammalian RTKs with the field of photo-oxygen-voltage sensing, a reversible light sensor that identifies Chlorella. In engineered receptors, the dimerization step and subsequent cellular signal transduction can now be turned on and off by light along with the algin protein and bind to each other. In tumor cells, activation of engineered receptors leads to changes in cell morphology, cell proliferation and gene expression, and increases the malignancy of cancers. In blood cells, activation leads to cell budding, typical neovascularization.
RTKs regulate development through photoactivation dimerization as the first instance of photoreactive dimerization of mammalian receptors. RTK under light control provides a powerful method of optogenetics to initiate cellular signaling and manipulate cellular behavior. The newly developed receptors trigger complex cellular activities of cancer and endothelial cells in the blood. These cells represent new models based on photocontrol behavior, as well as being able to identify new drugs with new methods. This is in contrast to cancer cells, where uncontrolled activation of cell signaling leads to malignancy-related features, and photo-activation of signal transduction may rescue the cell survival and function of degenerative diseases. "Asymptomatic" is a kind of motor neuron disease, patients gradually lose motor function or even paralysis, of which the most famous is the British scientist Hawking. The disease is thought to be associated with abnormalities in glial cells, which can be responsible for maintaining the network of nerve cells and providing nutrients to nerve cells.
A team led by Professor Inoue Ishiguro of Kyoto University used ips cells to make precursor cells that could be changed to glial cells. Then, about 80,000 of these 24 cells were transplanted into the spinal cord of 24 experimental mice with gradual freezing frost.
The results showed that the average survival time of 24 mice with asherogenic syndrome transplanted with precursor cells was 162 days compared to only 150 days with 24 mice without transplantation. The team said almost all of the transplanted precursor cells became astrocytes, one of the glial cells, and started producing the proteins needed to sustain the nerve cells, and none of the transplanted cells were cancerous.